Barclays PLC Assembly Biosciences, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$1.09 - $20.4 $1,379 - $25,826
-1,266 Reduced 3.4%
35,928 $47,000
Q3 2022

Nov 03, 2022
SELL
$1.7 - $20.52 $210,174 - $2.54 Million
-123,632 Reduced 76.87%
37,194 $61,000
Q2 2022

Aug 12, 2022
SELL
$1.35 - $2.29 $1,526 - $2,589
-1,131 Reduced 0.7%
160,826 $337,000
Q4 2021

Feb 14, 2022
SELL
$2.13 - $3.46 $108,678 - $176,539
-51,023 Reduced 23.96%
161,957 $378,000
Q3 2021

Nov 09, 2021
BUY
$3.14 - $3.9 $159,606 - $198,237
50,830 Added 31.35%
212,980 $742,000
Q2 2021

Aug 13, 2021
BUY
$3.8 - $4.56 $35,180 - $42,216
9,258 Added 6.06%
162,150 $628,000
Q1 2021

May 13, 2021
BUY
$4.33 - $6.63 $65,742 - $100,663
15,183 Added 11.03%
152,892 $703,000
Q4 2020

Feb 11, 2021
BUY
$4.87 - $17.29 $337,739 - $1.2 Million
69,351 Added 101.45%
137,709 $833,000
Q3 2020

Nov 12, 2020
SELL
$15.08 - $27.04 $1.34 Million - $2.41 Million
-88,960 Reduced 56.55%
68,358 $1.13 Million
Q2 2020

Aug 12, 2020
BUY
$14.57 - $23.96 $6,614 - $10,877
454 Added 0.29%
157,318 $3.67 Million
Q1 2020

May 13, 2020
BUY
$10.27 - $21.23 $106,910 - $221,004
10,410 Added 7.11%
156,864 $2.33 Million
Q4 2019

Feb 10, 2020
BUY
$8.36 - $23.81 $602,622 - $1.72 Million
72,084 Added 96.93%
146,454 $3 Million
Q3 2019

Nov 14, 2019
SELL
$9.83 - $14.82 $270,560 - $407,905
-27,524 Reduced 27.01%
74,370 $732,000
Q2 2019

Aug 14, 2019
BUY
$12.9 - $20.8 $1.21 Million - $1.96 Million
94,052 Added 1199.34%
101,894 $1.38 Million
Q1 2019

May 15, 2019
BUY
$17.7 - $24.93 $4,849 - $6,830
274 Added 3.62%
7,842 $155,000
Q4 2018

Feb 14, 2019
SELL
$19.05 - $36.45 $45,948 - $87,917
-2,412 Reduced 24.17%
7,568 $171,000
Q3 2018

Nov 14, 2018
BUY
$34.41 - $44.23 $199,268 - $256,135
5,791 Added 138.24%
9,980 $371,000
Q2 2018

Aug 14, 2018
SELL
$39.21 - $50.29 $156,840 - $201,160
-4,000 Reduced 48.85%
4,189 $165,000
Q1 2018

May 15, 2018
BUY
$41.7 - $64.16 $234,937 - $361,477
5,634 Added 220.51%
8,189 $402,000
Q4 2017

Feb 14, 2018
BUY
$28.58 - $49.91 $51,015 - $89,089
1,785 Added 231.82%
2,555 $116,000
Q3 2017

Nov 14, 2017
BUY
$23.08 - $34.92 $17,771 - $26,888
770
770 $27,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email